Top movers in Tuesday's after hours session Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why The company expects to soon expand from a single-product player to a "multi-product innovator."
EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q2 2024 EOLS stock results show that Evolus missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early The company reported $1.1 million in adjusted operating income, well ahead of expectations for a $2.6 million loss.
EOLS Stock Earnings: Evolus Beats EPS, Beats Revenue for Q1 2024 EOLS stock results show that Evolus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!
